Dynavax Technologies Corporation (DVAX) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Wyoming49 Wyoming49 01/27/2014 3 months $1.71 $1.50 -12.02% -12 Ended
Comments: Cautiously watching. Buy-out?
prometheusX prometheusX 01/24/2014 3 months $1.94 $1.58 -18.56% 18 Ended
Comments:
Steve57 Steve57 01/18/2014 3 months $2.07 $1.50 -27.54% -27 Ended
Comments: chart looking good. maybe buy-out target with $5-$7 per share soon
class1911 class1911 11/20/2013 1 week $1.50 $1.67 +11.71% -11 Ended
Comments: This stock is overvalued, BEWARE
tambor tambor 04/06/2013 1 month $2.39 $2.31 -3.35% -3 Ended
Comments:
JOKER66 JOKER66 02/25/2013 1 week $2.97 $1.98 -33.33% 33 Ended
Comments:
eflowers25 eflowers25 02/12/2013 1 month $3.22 $4.49 +39.44% 39 Ended
Comments: FDA decision on Feb 24th
SimiSchuster SimiSchuster 09/14/2012 3 months $4.55 $2.65 -41.76% -41 Ended
Comments: PDUFA in Nov 2012, partnerships with big pharma, % inst investors, short interest
moe1 moe1 12/09/2009 3 months N/A Ended
Comments:

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.